Zacks Investment Research
05 Aug 2026, 12:46 UTC · 1h ago
Perrigo (PRGO) Surpasses Q2 Earnings and Revenue Estimates
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
05 Aug 2026, 12:46 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Perrigo reported quarterly earnings of $0.50 per share, beating the Zacks Consensus Estimate of $0.31 per share. — A significant earnings beat of 61.29% typically triggers a positive short-term price reaction.
+0.60Perrigo's quarterly revenues reached $1.02 billion, surpassing the Zacks Consensus Estimate by 1.89%. — Revenue growth exceeding expectations is positive, though the beat is modest compared to the earnings surprise.
+0.30Perrigo's year-over-year quarterly revenue declined from $1.06 billion to $1.02 billion. — Declining annual revenue suggests a contraction in the business scale despite the quarterly beat.
-0.20Continue reading
6 related stories
Top 1 mover · tap to explore
Perrigo shares have declined approximately 22.6% since the beginning of the year, underperforming the S&P 500's 13% gain. — Strong year-to-date underperformance indicates negative sentiment and a bearish trend for the stock.
Which stocks this story touches
The company beat both earnings and revenue consensus estimates, delivering a significant earnings surprise of 61.29%.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
1h ago
